Discover advances in epilepsy treatments, innovative solutions for seizure freedom, and challenges in integrating new ...

Discover Booster Therapeutics' novel 20S proteasome activation approach to neurodegenerative diseases as it launches with $15 ...

Find out more about five biomimicry companies harnessing nature’s wisdom to create drug candidates for the benefit of human ...

Biotech IPO activity in the US has spiked for the second time this year, following an initial boost in Q1 2024. Largely ...

Take a closer look at 12 biotech unicorns, with a worth of more than $1 billion, that are trying to revolutionize the ...

There were a number of deals that stirred the biotech industry in September 2024. From a multibillion dollar deal to commercialize cell therapies to a new partnership model, a lot went down last month ...

Developing therapies for solid tumors remains a challenging task due to the heterogeneity of tumor tissues and the high variability between individual patients. Collecting tissue samples to analyze ...